In:
Obstetrical & Gynecological Survey, Ovid Technologies (Wolters Kluwer Health), Vol. 73, No. 8 ( 2018-8), p. 463-464
Kurzfassung:
(Abstracted from Sci Transl Med 2018;10:eaap8793) Although the Papanicolaou (Pap) test has dramatically decreased mortality from cervical cancer in the screened population, the test generally is unable to detect endometrial or ovarian cancers. These 2 cancers are usually diagnosed at an advanced stage when the prognosis is poor and treatment does not increase relative survival.
Materialart:
Online-Ressource
ISSN:
1533-9866
,
0029-7828
DOI:
10.1097/01.ogx.0000542325.60681.a3
Sprache:
Englisch
Verlag:
Ovid Technologies (Wolters Kluwer Health)
Publikationsdatum:
2018
ZDB Id:
2043471-6